CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2026-02-11 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2026-02-11 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +306,000 | 306,000 | ||
| 2026-02-11 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +131,000 | 131,000 | ||
| 2026-01-02 | Manji Husseini Director | Grant or award · Employee Stock Option (right to buy) | +4,228 | $11.82 | $50K | 4,228 |
| 2026-01-02 | York Gwill Director | Grant or award · Stock Option (right to buy) | +5,243 | $11.82 | $62K | 5,243 |
| 2026-01-02 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +7,189 | $11.82 | $85K | 7,189 |
| 2026-01-02 | Sanchez Ramiro Director | Grant or award · Stock Option (right to buy) | +3,806 | $11.82 | $45K | 3,806 |
| 2025-08-12 | Sanchez Ramiro Director | Grant or award · Stock Option (right to buy) | +30,574 | 30,574 | ||
| 2025-08-12 | Sanchez Ramiro Director | Grant or award · Stock Option (right to buy) | +3,928 | $2.21 | $9K | 3,928 |
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −8,000 | 0 | ||
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +188,000 | 188,000 | ||
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −188,000 | 0 | ||
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2025-07-03 | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +22,481 | 22,481 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −22,481 | 0 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +33,008 | 33,008 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −33,008 | 0 |
Page 2 of 7 · 125 trades